Andrew Levey, MD; Dr. Gerald J. and Dorothy R. Professor of Medicine, Tufts University School of Medicine, Boston, MA"The KDOQI Guidelines in many ways have allowed clinical research in chronic kidney disease to occur. Before the 2002 CKD Guideline, people were not even necessarily talking about the same thing when discussing kidney disease. The guideline allowed for the paradigm that we take for granted today - kidney disease is common and harmful, even at only moderately reduced glomerular filtration rates - and motivated detailed exploration into the harms associated with CKD including the high prevalence and incidence of cardiovascular disease, the management that people with CKD receive, and the gaps in knowledge that needed to be and, in many cases, still need to be filled."
Daniel Weiner, MD, MS; Associated Medical Director, Dialysis Clinic Inc., Boston, MA; Associate Professor, Tufts University School of Medicine, Boston, MA"KDOQI guidelines have been the model by which we establish our dialysis unit targets to assure quality patient care. It is the benchmark by which we set our Quality Improvement goals. KDOQI has been an outstanding asset in the management of Chronic Kidney Disease outcomes."
Judith Kirk, RD, CSR, CDN, FNKF; Rochester Regional Health Dialysis Center, Rochester, NY"The KDOQI guidelines and the subsequent commentaries are one of the major factors that helped to clarify and unify the definition of CKD as well as provide a basis for the development of algorithms for our nephrology practice CKD clinic. This has, over the years, had a major impact on improving the quality of care and the health of our CKD patients in our practice. Happy anniversary and thank you NKF for the forethought and assistance in putting together these guidelines."
Nelson Kopyt, MD; Chief, Division of Nephrology, Lehigh Valley Network, Allentown, PA"On this 20th anniversary of KDOQI, we should all reflect on how impactful the classification of chronic kidney disease has been on our practice and on improving the care of those with kidney disease. Continuing research in kidney disease will lead to further improved outcomes. KDOQI was a giant leap forward in kidney disease."
Beth Piraino, MD; University of Pittsburgh School of Medicine, Pittsburgh, PA
Past NKF President